Killip Classification Severity Tool for ACS

Killip Classification Severity Tool for Acute Coronary Syndrome: Explanation and Clinical Context The Killip classification is a bedside clinical scale that grades the severity of heart failure in the setting of acute myocardial infarction and acute coronary syndrome using simple physical examination findings including pulmonary rales third heart sound jugular venous pressure acute pulmonary edema and cardiogenic shock. Killip class I represents patients without clinical heart failure class II indicates mild heart failure with limited pulmonary congestion or third heart sound class III reflects overt acute pulmonary edema and class IV identifies cardiogenic shock with hypotension and signs of peripheral hypoperfusion. The original description showed a stepwise increase in in hospital mortality from roughly five to six percent for class I to more than eighty percent for class IV in patients with acute myocardial infarction treated in early coronary care units.

In the twenty twenty five guideline for the management of acute coronary syndrome from the American College of Cardiology and the American Heart Association signs of heart failure and pulmonary congestion are emphasized as key markers of higher risk during the initial evaluation of acute coronary syndrome. They are an integral component of the Killip classification and are incorporated into validated risk scores such as the Global Registry of Acute Coronary Events score the Thrombolysis In Myocardial Infarction risk score for ST segment elevation myocardial infarction and the Zwolle score which help estimate short term mortality and guide intensity of therapy and monitoring in acute coronary syndrome. Evidence summarized in the guideline highlights that higher Killip class at presentation is consistently associated with greater risk of death recurrent myocardial infarction and heart failure and therefore supports urgent reperfusion intensive care management and consideration of advanced hemodynamic support in patients with class III and class IV findings.

In clinical practice this tool is intended to standardize Killip class assignment document the severity of heart failure at presentation and provide an educational reminder of the associated mortality risk and recommended intensity of acute coronary syndrome care. It should be used together with full clinical assessment electrocardiographic findings biomarker data and formal risk scores rather than as a stand alone decision maker for individual therapies.